Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT06725758 |
| Title | A Phase 1/2, First-in-Human Study On ODM-212 In Subjects With Selected Advanced Solid Tumours (TEADES) |
| Acronym | TEADES |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Orion Corporation, Orion Pharma |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | GBR |